Amyris, Inc. (AMRS)

NASDAQ: AMRS · IEX Real-Time Price · USD
2.27
+0.12 (5.58%)
At close: Jun 24, 2022 4:00 PM
2.29
+0.02 (0.88%)
After-hours: Jun 24, 2022 7:37 PM EDT
5.58%
Market Cap 725.75M
Revenue (ttm) 222.67M
Net Income (ttm) -87.32M
Shares Out 319.71M
EPS (ttm) -0.39
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 6,759,940
Open 2.20
Previous Close 2.15
Day's Range 2.12 - 2.32
52-Week Range 1.47 - 17.19
Beta 1.66
Analysts Buy
Price Target 12.00 (+428.6%)
Earnings Date Aug 4, 2022

About AMRS

Amyris, Inc., a synthetic biotechnology company, operates in the clean health and beauty, and flavors and fragrance markets in Europe, North America, Asia, and South America. The company manufactures and sells clean beauty, personal care, and health and wellness consumer products, as well as ingredients to the flavor and fragrance, nutrition, food and beverage, and clean beauty and personal care end markets. It offers its products under the Biossance, Pipette, Purecane, Terasana, Costa Brazil, OLIKA, Rose Inc., and JVN brand names. The company ... [Read more...]

Industry Chemicals
IPO Date Sep 28, 2010
CEO John Melo
Employees 980
Stock Exchange NASDAQ
Ticker Symbol AMRS
Full Company Profile

Financial Performance

In 2021, Amyris's revenue was $341.82 million, an increase of 97.43% compared to the previous year's $173.14 million. Losses were -$270.97 million, -18.15% less than in 2020.

Financial Statements

Analyst Forecast

According to 13 analysts, the average rating for AMRS stock is "Buy." The 12-month stock price forecast is 12, which is an increase of 428.63% from the latest price.

Price Target
$12
(428.63% upside)
Analyst Consensus: Buy
Stock Forecasts

News

3 Short Squeeze Penny Stocks To Watch Before Next Week

Short squeeze penny stocks to watch. The post 3 Short Squeeze Penny Stocks To Watch Before Next Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Other symbols: FUVPEI

3 Tech Stocks at the Top of Our Watchlists

This basket of infrastructure software, technical instrument, and specialty chemicals stocks looks like a good value.

Other symbols: ADBECGNX

AMYRIS BARRA BONITA FERMENTATION PLANT BEGINS INDUSTRIAL PRODUCTION

EMERYVILLE, Calif. , June 23, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-t...

AMYRIS TO PARTICIPATE AT THE OPPENHEIMER 22nd ANNUAL CONSUMER CONFERENCE

EMERYVILLE, Calif. , June 7, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to...

3 Stocks Wall Street Thinks Could Triple Your Money or Better

Find out why the pros think these stocks could gain 200% or better.

Other symbols: LOVENVTA

AMYRIS PARTICIPATES IN INVESTOR CONFERENCES ON MAY 23, 24 AND 25, 2022

EMERYVILLE, Calif. , May 23, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to...

AMYRIS TO PARTICIPATE AT MAY INVESTOR CONFERENCES

EMERYVILLE, Calif. , May 23, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to...

Better Buy: Gingko Bioworks vs. Amyris

Which of these fallen stocks has the best chance of recovery?

Other symbols: DNA

Amyris (AMRS) Earnings and Revenues Lag Estimates in Q1

Amyris (AMRS) sees strong revenues in its consumer segment in Q1 driven by growth of its legacy brands and strong contribution from new brands.

Amyris, Inc. (AMRS) Reports Q1 Loss, Misses Revenue Estimates

Amyris, Inc. (AMRS) delivered earnings and revenue surprises of -54.17% and 11.83%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

AMYRIS, INC. REPORTS FIRST QUARTER 2022 FINANCIAL RESULTS

Record consumer revenue of $34.6 million increased 121% compared to Q1 2021 Barra Bonita commissioning on track to commence ingredients production in Q2 EMERYVILLE, Calif. , May 10, 2022 /PRNewswire/ --...

AMYRIS TO HOST FIRST QUARTER 2022 FINANCIAL RESULTS CONFERENCE CALL ON MAY 10

EMERYVILLE, Calif. , May 3, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-...

New Strong Sell Stocks for May 2nd

ALEC, AMRS, and BLFS have been added to the Zacks Rank #5 (Strong Sell) List on May 2, 2022

Other symbols: ALECBLFS

AMYRIS HOSTS SUCCESSFUL INVESTOR EVENT

EMERYVILLE, Calif. , April 14, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-...

AMYRIS STARTS COMMISSIONING OF INDUSTRY LEADING FERMENTATION PLANT

EMERYVILLE, Calif. , April 11, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-...

3 Top U.S. Stocks to Watch in April

Keep your eyes focused on these red, white, and blue businesses over the coming weeks?

Other symbols: MPRIVN

New Strong Sell Stocks for March 24th

GHM, AMRS, and GDOT have been added to the Zacks Rank #5 (Strong Sell) List on March 24, 2022

Other symbols: GDOTGHM

Will These Penny Stocks Explode in April? 3 to Watch This Week

Which penny stocks are you watching in April? The post Will These Penny Stocks Explode in April?

Other symbols: CCOGSAT

AMYRIS TO PARTICIPATE IN THE JEFFERIES VIRTUAL SYNTHETIC BIOLOGY WEEK

EMERYVILLE, Calif. , March 17, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-...

Amyris, Inc. (AMRS) Gains But Lags Market: What You Should Know

Amyris, Inc. (AMRS) closed at $3.96 in the latest trading session, marking a +1.02% move from the prior day.

AMYRIS CLOSES ACQUISITION OF MENOLABS

EMERYVILLE, Calif. , March 11, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-...

Amyris (AMRS) Q4 Earnings Lag Estimates, Sales Fall Y/Y

Amyris (AMRS) sees strong revenues in its consumer segment in Q4 driven by the accelerated growth of its consumer brands.

AMYRIS, INC. REPORTS FOURTH QUARTER AND FULL YEAR 2021 FINANCIAL RESULTS

EMERYVILLE, Calif., March 1, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to...

AMYRIS TO PRESENT AT THE 42nd ANNUAL COWEN HEALTH CARE CONFERENCE

EMERYVILLE, Calif. , Feb. 28, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-t...

AMYRIS TO HOST FOURTH QUARTER AND FULL YEAR 2021 FINANCIAL RESULTS CONFERENCE CALL ON MARCH 1

EMERYVILLE, Calif. , Feb. 22, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-t...